发明名称 Susceptibility variants for peripheral arterial disease and abdominal aortic aneurysm
摘要 The present invention discloses certain genetic variants as susceptibility variants for peripheral arterial disease (PAD) and abdominal aortic aneurysm (AAA). The invention relates to risk management using such variants. The invention further relates to kits for use in risk assessment of PAD and AAA.
申请公布号 US8808985(B2) 申请公布日期 2014.08.19
申请号 US200912935753 申请日期 2009.04.01
申请人 deCODE Genetics ehf. 发明人 Thorgeirsson Thorgeir;Sulem Patrick;Geller Frank;Magnusson Kristinn P.
分类号 C12P19/34 主分类号 C12P19/34
代理机构 Marshall, Gerstein & Borun LLP 代理人 Marshall, Gerstein & Borun LLP
主权项 1. A method for determining a susceptibility to peripheral arterial disease or abdominal aortic aneurysm in a human individual, the method comprising: analyzing polymorphic marker rs1051730 in a nucleic acid sample from the human individual, detecting the presence of allele T of polymorphic marker rs1051730 in the sample, determining an increased genetic susceptibility to peripheral arterial disease or abdominal aortic aneurysm for the individual attributable to the presence of allele T of polymorphic marker rs1051730 in the sample, and performing vascular imaging, segmental pressure measurement, or pulse volume recording on the individual identified as having the increased genetic susceptibility, to monitor the development, progress, and/or appearance of symptoms of peripheral arterial disease or performing angiography or ultrasound imaging on the individual identified as having the increased genetic susceptibility to abdominal aortic aneurism, to monitor the development, progress, and/or appearance of symptoms of abdominal aortic aneurism.
地址 Rekjavík IS